Stem cell therapy for multiple system atrophy
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a patient's own stem cells can help slow or improve symptoms of multiple system atrophy (MSA), a rare brain disorder. It may be an option for adults aged 35 to 65 with either the parkinsonian or cerebellar type of MSA.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with multiple system atrophy (either MSA-P or MSA-C).
- You are between 35 and 65 years old.
- You do not have another major neurological condition, like Parkinson's disease or Alzheimer's.
- You do not have severe heart, kidney, or liver problems.
- You have not had stem cell therapy before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether bone-marrow stem cells can improve nerve function in people with nerve damage that usually doesn’t recover with current care. It also checks whether the treatment is safe and whether people can be followed over time with repeated nerve exams.
This study tests whether injecting special dopamine-producing brain cells can help slow or improve symptoms in people with multiple system atrophy, a rare movement disorder similar to Parkinson's disease. The trial combines cell transplantation with brain imaging to measure safety and effectiveness.
This trial tests if using your own stem cells can stop multiple sclerosis that keeps getting worse despite treatment. You would first receive a medication to reset your immune system, then get your stem cells back to help rebuild it.
This phase 3 trial tests a new oral drug (MSA-01) for people with multiple system atrophy. It aims to see if the drug can slow disease progression and improve daily function.
This early-phase trial tests a new drug called ALT001 for people with multiple system atrophy (MSA). It aims to see if the drug is safe and may help slow the disease.
This trial tests a stem cell treatment to see if it can improve symptoms in people with Parkinson's disease or other similar conditions, like dementia with Lewy bodies or multiple system atrophy. It involves an injection of stem cells harvested from your own bone marrow.
Hear when a new MSA - Multiple System Atrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.